Gene-Targeted screening could catch prostate cancer earlier
NCT ID NCT07265414
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 23 times
Summary
This study looks at whether a new screening method using PHI and mp-MRI can find prostate cancer earlier in men with certain gene mutations (DRG). The goal is to see if this approach works better than the current standard of DRE and PSA tests. About 320 men with prostate or bladder cancer will take part. If successful, it could help catch more cancers early and reduce unnecessary treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IRCCS Humanitas Research Hospital
Milan, 20089, Italy
Conditions
Explore the condition pages connected to this study.